Drug Pricing Center
![pills-943764_1920[1]](https://eadn-wc03-6094147.nxedge.io/wp-content/uploads/2015/01/pills-943764_19201-1500x430.jpg)
Resources
Five Years of State Action to Lower Drug Prices: 2017-2021, May 2021
Pharmacy Cost Work Group MembersEd Achuck, Pharmacy Section Chief, California Department of General Services
Susan Barrett, Executive Director, Green Mountain Care Board, Vermont
Burl Beasley, Director, Pharmacy Services, Oklahoma Office of Management and Enterprise Services
Terry Cothran, Senior Pharmacy Director, Oklahoma Health Care Authority
James DeBenedetti, Director of Plan Management, Covered California
Richard Gottfried, State Assemblyman and Chair of Committee on Health, New York State Assembly, District 75
Kaha Hizanishvili, Chief, Provider and Pharmacy Programs, MassHealth, Massachussetts Executive Office of Health and Human Services
Sonya Jaquez Lewis, State Senator, Colorado State Senate, District 17
Eileen Mallow, Director, Office of Strategic Health Policy, Wisconsin Department of Employee Trust Funds
Kevin Martin, Pharmacy Rates Analyst, Colorado Department of Health Care Policy and Financing
Sara Sadownik, Deputy Director, Research and Cost Trends, Massachusetts Health Policy Commission
David Seltz, Executive Director, Massachusetts Health Policy Commission
Tricia Sieg, Pharmacy Benefit Program Manager, Wisconsin Department of Employee Trust Funds
Donna Sullivan, Chief Pharmacy Officer, Washington State Health Care Authority
Norman Thurston, State Representative, Utah House of Representatives, District 64
Joshua Wojcik, Assistant Comptroller, Connecticut Office of the Comptroller
Andrew York, Executive Director, Maryland Prescription Drug Affordability Board
To learn more about the Center or to receive state-only materials contact Jennifer Reck (jreck@oldsite.nashp.org)
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 
























































































































































What States Did in 2019 to Address Health Coverage and Costs
/in Policy Blogs, Featured News Home Administrative Actions, Eligibility and Enrollment, Essential Health Benefits, Health Coverage and Access, Medicaid Expansion, Newly-Enacted Laws, Prescription Drug Pricing, State Insurance Marketplaces, Work Requirements /by Sarah LanfordVermont Submits Concept Paper to Trump Administration to Import Drugs from Canada
/in Policy Vermont Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Legal Resources, Model Legislation, Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by Trish RileyWhat We’ve Learned from Early Adopters of Drug Price Transparency, and What We’ll Learn from the Next Wave
/in Policy California, Maine, Nevada, Oregon, Vermont Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Model Legislation, Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by Jennifer ReckAs prescription drug price increases greatly outpace inflation and new specialty drugs priced in the millions of dollars enter the market, several states have led the way as early adopters of drug price transparency legislation and are taking the first steps to curb costs with the help of transparent drug pricing information. Read NASHP’s new […]
What Are We Learning from State Reporting on Drug Pricing?
/in Policy California, Maine, Nevada, Oregon, Vermont Featured News Home, Reports Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Legal Resources, Model Legislation, Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by Deborah Chollet, PhD, William Mulhern, JD and Jia Pu, MA, PhD, MathematicaStates Assert their Drug Purchasing Power to Capture Savings for Medicaid
/in Medicaid Managed Care Ohio, Washington, West Virginia Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Model Legislation, Newly-Enacted Laws, Prescription Drug Pricing, Program Design, State Rx Legislative Action /by Johanna ButlerIn the face of rapidly rising prices, state Medicaid programs are asserting their prescription drug purchasing power through more active oversight of the administration of prescription drug benefits. As major drug purchasers, state Medicaid programs have leverage to lower costs without action from state legislatures. Ohio, Washington, and West Virginia have recently deployed a range […]
Meet NASHP’s New Center for Health System Costs Team
/in Policy Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Prescription Drug Pricing, Quality and Measurement, State Rx Legislative Action, Value-Based Purchasing /by Trish RileyThe National Academy for State Health Policy (NASHP) is pleased to announce two staff appointments to its new Center for Health System Costs. Deborah Fournier, JD, will serve as project director and Marilyn Bartlett, CPA, CMA, CFM, will join the team as a senior policy fellow. Fournier served as New Hampshire’s Medicaid director and led […]
New NASHP Tool Helps States Leverage Public Purchasing of Prescription Drugs
/in Policy California, Delaware, New Mexico Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Prescription Drug Pricing, State Rx Legislative Action /by Johanna Butler and Jennifer ReckAs state officials investigate reducing costs by leveraging their collective buying power to purchase prescription drugs, the National Academy for State Health Policy (NASHP) has developed a Checklist for Coordinating Public Purchasing of Prescription Drugs to help states establish baseline data across public purchasers and identify effective strategies to coordinate purchasing. The checklist is designed to […]
It’s Transparent: States Identify Costly Drugs, Including Drugs with Price Hikes Deemed Unsupported by Evidence
/in Policy Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by Jennifer Reck and Trish RileyThe same drugs that appear on state transparency reports identifying costly drugs also appear in an independent research institute’s report on drugs whose rapidly rising prices were not supported by new clinical evidence on the drugs’ safety or efficacy. The Institute for Clinical and Economic Review (ICER), an independent research organization that objectively evaluates prescription […]
A New Proposal to Lower Drug Costs by Allowing Individuals and Businesses to Join States’ Rx Purchasing Pools
/in Policy Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Legal Resources, Prescription Drug Pricing, State Rx Legislative Action /by Trish RileyNASHP’s Proposal for a State Purchasing Pool for Prescription Drugs
/in Policy Featured News Home, Reports Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Legal Resources, Prescription Drug Pricing, State Employee Health Plans, State Rx Legislative Action /by Erin Fuse Brown, JD, MPH and Mark D. Hunter, PhD, MPH